Don't miss MaximoWorld 2024, the premier conference on AI for asset management!

Experience the future of asset management with cutting-edge AI at MaximoWorld 2024.

Sign Up

Please use your business email address if applicable

GlaxoSmithKline uses Informance for Manufacturing Performance Business Intelligence

NORTHBROOK, IL - Informance International, a leader in manufacturing business intelligence and enterprise manufacturing intelligence solutions announces that GlaxoSmithKline plc (GSK), one of the world’s leading research-based pharmaceutical and health care companies, has fully deployed Informance solutions and advisory services in their Clifton, New Jersey and Aiken, South Carolina manufacturing facilities as part of a global framework agreement for global business intelligence to drive and sustain manufacturing operations performance. Under the agreement, GlaxoSmithKline names Informance as a preferred solution to assess improvement opportunities, align plant tactics with corporate strategies, and exercise the most efficient use of the information to sustain the effects of operational excellence activities.

Pharmaceutical manufacturers are under tremendous pressure to increase product volume in their own plants, in order to reduce contract manufacturing and improve margins. They must often achieve this higher volume with optimized resources - a challenging task without the help of real-time discovery analytics for operational excellence. They usually find that simple OEE tools are not adequate to drive the improvement agenda, and leading manufacturers, especially pharmaceutical companies, look to solutions that deliver facts, pervasive visibility, and maximum knowledge transfer, along with real data, actual root cause analytics, and a deep understanding of problems.

“While OEE is often an important first step in an improvement initiative, it’s not until plant and executive management can quantify and report the financial impact of performance improvements that manufacturers begin to see a contribution to financial performance,” reports John Oskin, Executive Vice President of Informance. “Manufacturers like GlaxoSmithKline use Informance solutions together with IMPACT services to help discover and evaluate opportunities in manufacturing, so that they can take action on those that add the greatest benefit.”

About GlaxoSmithKline
GlaxoSmithKline is one of the world’s leading research-based pharmaceutical and health care companies - committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information please visit

About Informance International
Informance delivers Enterprise Manufacturing Intelligence (EMI) solutions to help clients accelerate operational performance initiatives, drive operating strategies and capture actionable insight; measured by speed-to-value. Using Informance, manufacturing teams can drive corporate initiatives like Lean, Six Sigma, TPM, and other continuous improvement methods. Clients quickly unlock hidden capacity, increase productivity without additional capital investment, reduce inventory and labor costs, and increase working capital. To learn more, call 1-877-464-6262 or visit

ChatGPT with
Find Your Answers Fast